Advertisement
Screener

Protagenic Therapeutics, Inc.\new (PTIX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Protagenic Therapeutics, Inc.\new Cash Flow Breakdown

Cash flow breakdown shows where Protagenic Therapeutics, Inc.\new's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-06-30: from running the business, $2.00M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$2.00M*
2026-03-31-$2.81M$629.88K$395.47K$3.48M*$1.70M
2025-12-31-$4.14M*$395.47K*$4.11M*
2025-06-30-$3.49M*$395.47K*$5.95M*
2025-03-31-$1.77M$200.00$1.81M*$40.36K
2024-12-31-$4.22M$2.80M$1.96M*$550.58K
2024-06-30-$3.71M*$5.67M*
2024-03-31-$4.99M*$5.68M*
2023-12-31-$3.70M$4.78M$1.07M
2023-06-30-$2.62M*$2.43M*
2023-03-31-$1.94M*$1.52M*
2022-12-31-$1.99M$1.60M-$325.98K
2022-06-30-$2.76M*
2022-03-31-$2.62M*
2021-12-31-$2.80M-$9.91M$12.58M*-$129.92K
2021-06-30-$2.16M*$12.90M*
2021-03-31-$1.59M*$1.02M*
2020-12-31-$1.35M$1.22M*-$127.53K
2020-06-30-$721.28K*
2020-03-31-$656.38K*
2019-12-31-$487.99K$250.00K$670.00K*$436.14K
2019-06-30-$744.23K*$853.02K*
2019-03-31-$1.01M*$1.09M*$76.05K*
2018-12-31-$1.07M$1.05M-$37.20K
2018-06-30-$1.38M*$985.41K*-$391.81K*
2018-03-31-$1.28M*-$2.40M*
2017-12-31-$1.38M-$1.29M-$2.70M
2017-06-30-$1.24M*-$3.16M*
2017-03-31-$1.44M*-$1.01M*
2016-12-31-$1.14M$6.50K$4.28M*$3.10M
2016-06-30-$710.44K*$4.45M*$3.73M*
2016-03-31-$323.88K*$4.05M*$3.69M*
2015-12-31-$381.34K-$1.79K-$19.39K
2015-06-30-$378.00K-$1.00K-$39.00K
2015-03-31-$287.00K*-$1.00K*-$59.92K*
2014-12-31-$155.97K$0.00*-$133.25K
2014-06-30-$790.00K-$1.00K-$616.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$944.30K-$944.30K
2026-03-31$265.53K*-$313.30K*$0.00*-$533.90K*
2025-12-31-$509.67K*$0.00*$0.00*
2025-09-30-$811.52K*$0.00*$0.00*-$599.28K*
2025-06-30-$1.75M$943.18K$395.47K$4.61M*$4.20M
2025-03-31-$1.07M$0.00*-$965.51K
2024-12-31-$353.64K*-$1.22M*$0.00*$1.37M*
2024-09-30-$317.44K*$0.00*$0.00*
2024-06-30-$246.43K$1.60M*$200.00$962.42K*$716.19K
2024-03-31-$1.66M$1.20M-$456.12K
2023-12-31-$1.14M*$2.28M*
2023-09-30-$655.77K*$590.72K*
2023-06-30-$1.53M*$1.61M*
2023-03-31-$371.83K$294.67K-$76.70K
2022-12-31-$180.94K*$161.77K*
2022-09-30-$535.23K*$357.53K*
2022-06-30-$847.08K*$706.92K*
2022-03-31-$430.56K$370.76K-$59.00K
2021-12-31-$405.09K*$485.95K*
2021-09-30-$1.08M*$0.00*
2021-06-30-$710.38K*$532.50K$11.92M*
2021-03-31-$607.71K-$479.42K
2020-12-31-$320.87K*
2020-09-30-$517.81K*
2020-06-30-$145.69K*$570.00K*
2020-03-31-$364.41K-$44.65K
2019-12-31-$149.42K*$0.00*
2019-09-30-$61.76K*$0.00*
2019-06-30-$80.79K*$0.00*
2019-03-31-$196.01K$250.00K$56.85K
2018-12-31-$307.79K*$245.50K*-$69.45K*
2018-09-30-$159.63K*$357.52K*$195.92K*
2018-06-30-$344.75K*$237.31K*-$107.27K*
2018-03-31-$259.01K$205.33K-$56.40K
2017-12-31-$417.02K*-$133.68K*-$552.45K*
2017-09-30-$358.80K*$676.44K*$324.31K*
2017-06-30-$246.88K*-$2.12M*
2017-03-31-$357.40K-$355.40K
2016-12-31-$341.81K*-$388.58K*
2016-09-30-$296.07K*-$299.21K*
2016-06-30-$445.05K*$505.19K*$37.42K*
2016-03-31-$57.39K$3.80M*$3.75M
2015-12-31-$106.00K*-$6.00K*
2015-09-30-$102.00K$163.95K*-$52.00K
2015-06-30-$58.48K*$0.00*$4.53K*
2015-03-31-$9.00K-$1.00K*-$21.93K
2014-12-31-$111.00K*$0.00*$39.00K*
2014-09-30-$80.00K$0.00$10.00K
2014-06-30-$87.00K*$0.00*-$87.00K*
2014-03-31-$116.00K*$0.00*$59.00K*
2013-12-31-$151.00K*$0.00*-$151.00K*
2013-09-30-$436.00K-$1.00K-$437.00K
2011-09-30-$74.00K*-$220.00K*-$1.00K*-$311.00K*
2010-09-30-$3.37M*$357.00K*$0.00*-$3.02M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
CDT Equity Inc. (CDT)United States$0.000B-0.01
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Aditxt, Inc. (ADTX)United States$0.000B
Rafael Holdings, Inc. (RFL)United States$0.000B-0.00